Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.45% to $495.42 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to ...

Alongside this dynamic new model, Google also unveiled ShieldGemma 2. In a push for responsible AI image generation, ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ...

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Google introduced Gemma 3, a new series of open-source AI models designed for superior performance and accessibility, in a bid to compete with AI gian ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Verona Pharma (VRNA – Research Report). The company’s ...

Gemma 3 models are capable of processing text and visual inputs but can only generate text outputs. The models are available ...

About 52 per cent of employees experience burnout due to poor work-life balance, showed a survey conducted in five states in ...

Google has released four new open-source AI models under the Gemma 3 series, which are tailor-made for deploying on mobile platform and beat OpenAI while at it.

For its FY2024 ended Dec 31, 2024, 17Live announced a loss of about US$3.3 million ($4.4 million), narrowing from a loss of ...